PBT 0.00% 0.0¢ prana biotechnology limited

Given the market crashing over the last few months, this funding...

  1. 1,382 Posts.
    lightbulb Created with Sketch. 54
    Given the market crashing over the last few months, this funding gets rid of any time delays in securing finances for phase 2 drug development.

    With Trumps unpredictability, financial stability and drug development continuity is a major milestone in this announcement. You only have to look at some other ASX bios to realise how crucial funding is when at all time lows.

    Now we have a clear path forward and surety in moving onwards and upwards and is very important for anyone that remembers delays caused with last market crash.

    Once phase 1 is finalised and phase 2 is announced, rerating is inevitable ( just depends what price point you want to jump in at right now).

    Prana has a great story to tell and deliver on it, it just hasn’t been communicated well to this point IMO.
    Last edited by pierre77: 29/12/18
 
watchlist Created with Sketch. Add PBT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.